by OpenAIUS
Speed up drug discovery and biology research by letting scientists hand multi-step analysis, literature review and experiment planning to an AI, while keeping biology misuse risks under control.
Out of preview since Sep 2026: gated to vetted orgs worldwide; paid API billing from 5 Oct 2026.
Updated 30d agoChecked 11 Oct0 updates this week
It starts from OpenAI's frontier reasoning model and is tuned for protein and chemistry reasoning, genomics and lab protocols.
Plugins connect it to 50+ public sources such as AlphaFold and BindingDB, and to sequencing-analysis pipelines, so answers cite real data.
In ChatGPT, Codex or the API it can search literature, write and run analysis code and show sequences and structures in built-in viewers.
Users must show legitimate research, governance and controlled access, because the same skills could help someone misuse biology.
| Spec | GPT-Rosalind |
|---|---|
| BixBench pass@1 (Apr 2026) | 0.751R (reported) |
| LABBench2 tasks beating GPT-5.4 | 6 of 11R (reported) |
| LabWorkBench (Jun 2026) | 63.2%R (reported) |
| MedChemBench (Jun 2026) | 27.5%R (reported) |
| Databases linked by research plugin | 50+R (reported) |
| Fewer tokens on long genomics tasks | 31% vs GPT-5.5R (reported) |
| API price per M tokens (in / out) | $5 / $25R (reported) |
R reported by the company
OpenAI
ChatGPT, GPT models, Codex, Stargate
OpenAI makes ChatGPT and the GPT models behind it. ChatGPT's launch in November 2022 made AI chatbots mainstream. It also builds huge data centers through the Stargate project.
